DNA-Encoded Library Technology─A Catalyst for Covalent Ligand Discovery.

Area of Science:

• Medicinal Chemistry
• Chemical Biology
• Drug Discovery

Background:

• Historically, identifying novel covalent ligands relied on serendipity, with dedicated techniques emerging in the early 2000s.
• Chemoproteomics advances enable robust characterization of covalent drugs, mitigating associated liabilities and renewing interest in this modality.
• DNA-encoded library (DEL) technology has become a powerful tool for identifying novel chemical matter against protein targets.

Purpose of the Study:

• To explore current approaches in covalent DNA-encoded library (DEL) technology.
• To reflect on the future directions and advancements needed to fully realize the potential of DEL for covalent ligand discovery.

Main Methods:

• Review of existing literature and methodologies in covalent DEL synthesis.
• Analysis of chemoproteomic approaches for characterizing covalent hit molecules.
• Discussion of challenges and opportunities in covalent DEL hit identification.

Main Results:

• Several commercial and academic groups have reported methods for covalent DEL synthesis and hit identification.
• Despite progress, significant potential remains untapped in applying DEL technology for covalent ligand discovery.
• Chemoproteomics plays a crucial role in derisking covalent hit molecules.

Conclusions:

• Covalent ligand discovery using DEL technology is a rapidly advancing field with significant therapeutic potential.
• Further innovation in covalent DEL synthesis and screening methodologies is required.
• Integrating chemoproteomics is essential for successful covalent drug development.